{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:04:07Z","timestamp":1765713847546},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T00:00:00Z","timestamp":1325635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00296-011-2295-y","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T06:33:26Z","timestamp":1325572406000},"page":"51-55","source":"Crossref","is-referenced-by-count":13,"title":["High risk of osteonecrosis of the femoral head in autoimmune disease patients showing no immediate increase in hepatic enzyme under steroid therapy"],"prefix":"10.1007","volume":"33","author":[{"given":"Shunichiro","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nagoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohisa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tateda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,4]]},"reference":[{"issue":"5","key":"2295_CR1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archinte.1978.03630290052018","volume":"138","author":"M Abeles","year":"1978","unstructured":"Abeles M, Urman JD, Rothfield NF (1978) Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med 138(5):750\u2013754","journal-title":"Arch Intern Med"},{"issue":"5","key":"2295_CR2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2106\/JBJS.E.01041","volume":"88","author":"MA Mont","year":"2006","unstructured":"Mont MA, Jones LC, Hungerford DS (2006) Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88(5):1117\u20131132. doi: 10.2106\/JBJS.E.01041","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"2295_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/kei149","volume":"45","author":"T Ichiseki","year":"2006","unstructured":"Ichiseki T (2006) Oxidative stress by glutathione depletion induces osteonecrosis in rats. Rheumatology 45(3):287\u2013290. doi: 10.1093\/rheumatology\/kei149","journal-title":"Rheumatology"},{"issue":"7","key":"2295_CR4","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/art.30365","volume":"63","author":"T Ichiseki","year":"2011","unstructured":"Ichiseki T, Kaneuji A, Ueda Y, Nakagawa S, Mikami T, Fukui K, Matsumoto T (2011) Osteonecrosis development in a novel rat model characterized by a single application of oxidative stress. Arthritis Rheum 63(7):2138\u20132141. doi: 10.1002\/art.30365","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2295_CR5","first-page":"609","volume":"26","author":"JT Moskal","year":"1997","unstructured":"Moskal JT, Topping RE, Franklin LL (1997) Hypercholesterolemia: an association with osteonecrosis of the femoral head. Am J Orthop 26(9):609\u2013612","journal-title":"Am J Orthop"},{"key":"2295_CR6","unstructured":"Jones JP Jr (1992) Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res 277:41\u201353"},{"issue":"4","key":"2295_CR7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clpt.2006.07.004","volume":"80","author":"Y Kaneshiro","year":"2006","unstructured":"Kaneshiro Y, Oda Y, Iwakiri K, Masada T, Iwaki H, Hirota Y, Kondo K, Takaoka K (2006) Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther 80(4):396\u2013402. doi: 10.1016\/j.clpt.2006.07.004","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2295_CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/ken462","volume":"48","author":"S Okazaki","year":"2009","unstructured":"Okazaki S, Nishitani Y, Nagoya S, Kaya M, Yamashita T, Matsumoto H (2009) Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway. Rheumatology 48(3):227\u2013232. doi: 10.1093\/rheumatology\/ken462","journal-title":"Rheumatology"},{"issue":"12","key":"2295_CR9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.60.12.1145","volume":"60","author":"K Oinuma","year":"2001","unstructured":"Oinuma K (2001) Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis 60(12):1145\u20131148. doi: 10.1136\/ard.60.12.1145","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2295_CR10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s007760200108","volume":"7","author":"N Sugano","year":"2002","unstructured":"Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K (2002) The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci 7(5):601\u2013605. doi: 10.1007\/s007760200108","journal-title":"J Orthop Sci"},{"issue":"10","key":"2295_CR11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/rheumatology\/keh721","volume":"44","author":"T Kabata","year":"2005","unstructured":"Kabata T (2005) Onset of steroid-induced osteonecrosis in rabbits and its relationship to hyperlipaemia and increased free fatty acids. Rheumatology 44(10):1233\u20131237. doi: 10.1093\/rheumatology\/keh721","journal-title":"Rheumatology"},{"key":"2295_CR12","doi-asserted-by":"crossref","unstructured":"Cui Q, Wang GJ, Su CC, Balian G (1997) The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res 344:8\u201319","DOI":"10.1097\/00003086-199711000-00003"},{"issue":"5","key":"2295_CR13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00776-008-1257-z","volume":"13","author":"K Iwakiri","year":"2008","unstructured":"Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Masada T, Kobayashi A, Asada A, Takaoka K (2008) Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model. J Orthop Sci 13(5):463\u2013468. doi: 10.1007\/s00776-008-1257-z","journal-title":"J Orthop Sci"},{"issue":"2","key":"2295_CR14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ocl.2009.01.004","volume":"40","author":"M Ajmal","year":"2009","unstructured":"Ajmal M, Matas AJ, Kuskowski M, Cheng EY (2009) Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am 40(2):235\u2013239. doi: 10.1016\/j.ocl.2009.01.004","journal-title":"Orthop Clin North Am"},{"key":"2295_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pa.19.040179.001143","volume":"19","author":"JE Parrillo","year":"1979","unstructured":"Parrillo JE, Fauci AS (1979) Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol 19:179\u2013201. doi: 10.1146\/annurev.pa.19.040179.001143","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5234","key":"2295_CR16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N Auphan","year":"1995","unstructured":"Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270(5234):286\u2013290","journal-title":"Science"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2295-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2295-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:35Z","timestamp":1559028095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2295-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,4]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2295"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2295-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,4]]}}}